Study of ACE-536 in Healthy Postmenopausal Women
Completed · Phase 1 · Has a placebo group
Conditions studied: Anemia
In brief
The purpose of this study is to find out whether ACE-536 can be safely given to patients. This study will also look to see if ACE-536 increases red blood cells, the cells that carry oxygen in the body.
Key facts
- Study ID
- NCT01432717
- Run by
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- People needed
- 40
- Starts
- 2011-09-01
- Expected to finish
- 2012-10-01
- Last updated by the study team
- 2012-11-07
Who can join
Age: 45 and older, up to 75. Sex: female. Healthy volunteers: accepted.
Where it is running
- Acceleron Investigative Site — Tempe, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.